Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01580553

The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure

The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure -A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study

Sponsor: Lee's Pharmaceutical Limited

Conditions Heart Failure,

Interventions Levocarnitine Injection Levocarnitine placebo

Updated 6 times since 2017 Last updated: Apr 26, 2012 Started: Jan 31, 2011 Primary completion: Mar 31, 2012 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Heart Failure, and is currently completed. Lee's Pharmaceutical Limited leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Sep 2020 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Sep 2020 [monthly]

Completed PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lee's Pharmaceutical Limited

Data source: Lee's Pharmaceutical Limited

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China